3.2. Reversal of Altered CML Hematological Parameters after SOS1 (But Not SOS2) Ablation in p210BCR/ABL Transgenic Mice. This evidence concerns the gene SOS2 and chronic myelogenous leukemia, BCR-ABL1 positive.